Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

227 views

Visitors from

US 53%·

AU 33%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

2 Nasdaq 100 Stocks with Competitive Advantages and 1 We Question

By: StockStory

May 04, 2026 at 00:33 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

WDAY Cover Image

The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.

Even among high-growth companies, some are struggling, which is why we built StockStory - to help you separate winners from losers. That said, here are two Nasdaq 100 stocks that could lead the market and one that may face some trouble.

One Stock to Sell:

Workday (WDAY)

Market Cap: $32.63 billion

Born from the vision of PeopleSoft founders after Oracle's hostile takeover of their previous company, Workday (NASDAQ: WDAY) provides cloud-based software for financial management, human resources, planning, and analytics to help organizations manage their business operations.

Why Are We Wary of WDAY?

Underwhelming ARR growth of 12.5% over the last year suggests the company faced challenges in acquiring and retaining long-term customers
Estimated sales growth of 11.5% for the next 12 months implies demand will slow from its two-year trend
Operating margin improvement of 2.6 percentage points over the last year demonstrates its ability to scale efficiently

Workday’s stock price of $126.31 implies a valuation ratio of 3x forward price-to-sales. Check out our free in-depth research report to learn more about why WDAY doesn’t pass our bar.

Two Stocks to Watch:

Marvell Technology (MRVL)

Market Cap: $144.2 billion

Moving away from a low margin storage device management chips in one of the biggest semiconductor business model pivots of the past decade, Marvell Technology (NASDAQ: MRVL) is a fabless designer of special purpose data processing and networking chips used by data centers, communications carriers, enterprises, and autos.

Why Are We Positive On MRVL?

Market share has increased this cycle as its 22.5% annual revenue growth over the last five years was exceptional
Operating margin expanded by 23.9 percentage points over the last five years as it scaled and became more efficient
Incremental sales over the last five years have been more profitable as its earnings per share increased by 25.1% annually, topping its revenue gains

At $164.65 per share, Marvell Technology trades at 43.2x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Amgen (AMGN)

Market Cap: $178 billion

Founded in 1980 during the early days of the biotechnology revolution, Amgen (NASDAQ: AMGN) is a biotechnology company that discovers, develops, and manufactures innovative medicines to treat serious illnesses like cancer, osteoporosis, and autoimmune diseases.

Why Are We Fans of AMGN?

Solid 12.3% annual revenue growth over the last two years indicates its offering’s solve complex business issues
Economies of scale give it more fixed cost leverage than its smaller competitors
AMGN is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders

Amgen is trading at $329.39 per share, or 5x forward price-to-sales. Is now the time to initiate a position? See for yourself in our full research report, it’s free.

Stocks We Like Even More

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	272.68	+1.51 (0.56%)
AAPL	293.32	+5.88 (2.05%)
AMD	455.19	+46.73 (11.44%)
BAC	51.31	-1.44 (-2.73%)
GOOG	397.05	+1.75 (0.44%)
META	609.63	-7.18 (-1.16%)
MSFT	415.12	-5.65 (-1.34%)
NVDA	215.20	+3.70 (1.75%)
ORCL	195.95	+1.36 (0.70%)
TSLA	428.35	+16.56 (4.02%)